Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) – Financial and Strategic SWOT Analysis Review – new company profile report – Transworld News

Jingxin Pharma’s products include APIs, comprising levofloxacin hemihydrate, ciprofloxacin HCL, ofloxacin, gatifloxacin, simvastatin, and other bulk drugs; finished dosage forms, including simvastatin tablets, loratadine tablets, cisapride tablets …

Leave a Reply

Your email address will not be published.